These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7564341)

  • 1. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium.
    Sakai R; Inoue D; Ishibashi K; Inoue M; Shirayama T; Yamahara Y; Asayama J; Nakagawa M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):953-60. PubMed ID: 7564341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
    Shirayama T; Inoue D; Inoue M; Tatsumi T; Yamahara Y; Asayama J; Katsume H; Nakagawa M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):884-93. PubMed ID: 1658312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of depressant effects of class I antiarrhythmic drugs on intraventricular conduction--rate-dependent effects on QRS duration].
    Ikeda N; Kamiya K
    Jpn Circ J; 1992; 56 Suppl 5():1477-9. PubMed ID: 1337924
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Hattori Y; Hidaka T; Aisaka K; Satoh F; Ishihara T
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
    Yokota M; Toyama J; Ukai M; Miyahara T; Koide M; Kato R; Yasui S; Sotobata I
    Jpn Circ J; 1992; 56 Suppl 5():1480-4. PubMed ID: 1291746
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined class I antiarrhythmic agents have differential effects on tonic and use dependent block of maximum rate of depolarisation of action potentials in guinea pig cardiac muscle.
    Nitta J; Sunami A; Furukawa T; Marumo F; Sawanobori T; Hiraoka M
    Cardiovasc Res; 1992 May; 26(5):462-9. PubMed ID: 1332827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
    Inoue M; Inoue D; Ishibashi K; Sakai R; Omori I; Yamahara Y; Asayama J; Nakagawa M
    Jpn Heart J; 1993 May; 34(3):301-12. PubMed ID: 8411636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 13. Complex frequency-dependent interaction of class-I antiarrhythmic drugs as they affect intraventricular conduction.
    Lee JK; Takanaka C; Nonokawa M; Kato H; Yabe S; Kodama I; Toyama J
    Eur Heart J; 1995 Jun; 16(6):832-41. PubMed ID: 7588928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
    Campbell TJ
    J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of drugs on the relationship between sinus node recovery time and calculated sinoatrial conduction time in man.
    Breithardt G; Seipel L
    Basic Res Cardiol; 1978; 73(1):68-76. PubMed ID: 656018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide.
    Homma N; Tsujimoto G; Hashimoto K
    Jpn J Pharmacol; 2001 May; 86(1):23-31. PubMed ID: 11430469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise time of the monophasic action potential--a new index of local use-dependent conductivity by sodium channel blockers in human myocardium.
    Shinozaki T; Satoh S; Miura M; Iwabuchi K; Takeuchi M; Suzuki S; Baba S; Katoh H; Funakoshi M; Keitoku M; Watanabe J; Ishide N; Shirato K
    Jpn Circ J; 1997 Dec; 61(12):979-87. PubMed ID: 9412861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of inactivated sodium channel blockers causes competitive interaction on dV/dtmax of single ventricular myocytes.
    Kamiya K; Kodama I; Toyama J
    Cardiovasc Res; 1991 Jun; 25(6):516-22. PubMed ID: 1653644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.